Clarivate (NYSE:CLVT) Shares Gap Down – What’s Next?

Clarivate PLC (NYSE:CLVT) shares gapped down prior to trading on Thursday . The stock had previously closed at $2.21, but opened at $2.12. Clarivate shares last traded at $2.1350, with a volume of 128,089 shares changing hands.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CLVT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Barclays raised their price objective on Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a research report on Tuesday. Finally, Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Five analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $3.23.

Clarivate Stock Performance

The stock has a fifty day moving average price of $2.41 and a 200 day moving average price of $2.55. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -10.26 and a beta of 1.38.

Clarivate (NYSE:CLVT) last posted its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.04. The firm had revenue of $585.50 million during the quarter, compared to analyst estimates of $569.50 million. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, analysts predict that Clarivate PLC will post 0.65 earnings per share for the current year.

Institutional Trading of Clarivate

A number of institutional investors and hedge funds have recently modified their holdings of the company. Parallel Advisors LLC boosted its holdings in shares of Clarivate by 94.2% during the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after buying an additional 6,687 shares during the period. Amundi boosted its holdings in Clarivate by 1,670.2% during the first quarter. Amundi now owns 558,992 shares of the company’s stock valued at $1,414,000 after acquiring an additional 527,414 shares during the period. Royal Bank of Canada grew its position in shares of Clarivate by 44.8% in the first quarter. Royal Bank of Canada now owns 32,818 shares of the company’s stock valued at $83,000 after purchasing an additional 10,149 shares during the last quarter. Empowered Funds LLC grew its position in shares of Clarivate by 418.6% in the first quarter. Empowered Funds LLC now owns 2,015,829 shares of the company’s stock valued at $5,100,000 after purchasing an additional 1,627,159 shares during the last quarter. Finally, FreeGulliver LLC bought a new position in shares of Clarivate in the first quarter worth about $30,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.